Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

Published:2013-02-27 Issue:6 Volume:105 Page:405-423
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Chen Min,Gallipoli Paolo,DeGeer Donna,Sloma Ivan,Forrest Donna L.,Chan Matthew,Lai Damian,Jorgensen Heather,Ringrose Ashley,Wang Hui Mi,Lambie Karen,Nakamoto Helen,Saw Kyi Min,Turhan Ali,Arlinghaus Ralph,Paul James,Stobo Jon,Barnett Michael J.,Eaves Allen,Eaves Connie J,Holyoake Tessa L.,Jiang Xiaoyan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/6/405/17312808/djt006.pdf

Reference70 articles.

1. Chronic myeloid leukemia;Sawyers;N Engl J Med,1999

2. Chronic myeloid leukemia—advances in biology and new approaches to treatment;Goldman;N Engl J Med,2003

3. Insights into the stem cells of chronic myeloid leukemia;Sloma;Leukemia,2010

4. Critical molecular pathways in cancer stem cells of chronic myeloid leukemia;Chen;Leukemia,2010

5. Molecular mechanisms of transformation by the BCR-ABL oncogene;Sattler;Semin Hematol,2003

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editor’s Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex;JNCI: Journal of the National Cancer Institute;2024-07-11

2. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023

3. GENETIC CHIMERISM IN MYELOPROLIFERATIVE NEOPLASMS: CLINICAL CASE OF COEXISTENCE OF JAK2V617F MUTATION AND BCR-ABL TRANSLOCATION;Laboratornaya i klinicheskaya meditsina. Farmatsiya;2023

4. Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias;Biomedicines;2022-07-30

5. Multiple gene knockdown strategies for investigating the properties of human leukemia stem cells and exploring new therapies;Methods in Cell Biology;2022